Evidence map›Paper›PMID 38648977›Full record

ReviewThe journal of allergy and clinical immunology. In practice2024

Understanding Health Equity in Patient-Reported Outcomes.

Lourdes G Ramirez, Margee Louisias, Princess U Ogbogu, Alanna Stinson, Ruchi Gupta, Samantha Sansweet, Tarandeep Singh, Andrea Apter, Bridgette L Jones, Sharmilee M Nyenhuis

Abstract readReview
In one paragraph

Review in The journal of allergy and clinical immunology. In practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lourdes G RamirezDivision of Allergy and Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass.
Margee LouisiasDivision of Allergy and Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass.
Princess U OgboguDivision of Pediatric Allergy, Immunology, and Rheumatology, University Hospitals Rainbow Babies and Children's Hospital, Cleveland, Ohio; Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Alanna StinsonSection of Allergy, Immunology, and Pediatric Pulmonology, Department of Pediatrics, University of Chicago, Chicago, Ill.
Ruchi GuptaCenter for Food Allergy and Asthma Research, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill; Division of Advanced General Pediatrics and Primary Care, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.
Samantha SansweetCenter for Food Allergy and Asthma Research, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill; Division of Advanced General Pediatrics and Primary Care, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.
Tarandeep SinghSection of Allergy and Immunology, Division of Pulmonary, Allergy, and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.
Andrea ApterSection of Allergy and Immunology, Division of Pulmonary, Allergy, and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.
Bridgette L JonesDepartment of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Mo; Children's Mercy Hospital, Section of Allergy/Immunology and Division of Pediatric Clinical Pharmacology and Therapeutic Innovation, Kansas City, Mo.
Sharmilee M NyenhuisSection of Allergy, Immunology, and Pediatric Pulmonology, Department of Pediatrics, University of Chicago, Chicago, Ill. Electronic address: snyenhuis@bsd.uchicago.edu.

Funding

Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
NIEHS NIH HHS P30 ES027792
6 · The paper itself

Abstract

Patient-reported outcomes (PROs) are measures of patients' health that are conveyed directly by individual patients. These measures serve as instruments to evaluate the impact of interventions on any aspect of patients' health, from specific symptoms to broader quality of life indicators. However, their effectiveness relies on capturing relevant factors accurately. Whereas they are commonly used in clinical trials, PROs extend their influence across health care settings, informing clinicians, health care payers, regulators, and administrators to guide quality improvement and reimbursement decisions. Neglecting health equity considerations in PRO development and implementation widens health disparities, leading to biased interpretations, medical mismanagement, and poor health outcomes among marginalized groups. To foster equitable health care, efforts must focus on considering the values of underrepresented populations in PRO design, addressing barriers to completion, enhancing representation in research, providing cultural competency training for clinicians, and allocating research funding to support health equity research. By addressing these issues, advances can be made toward fostering inclusive, equitable health care for all individuals.

Indexed as

Health EquityPatient Reported Outcome MeasuresHealthcare DisparitiesHumansAllergy/immunologyHealth disparitiesHealth equityPatient-reported outcomes

Identifiers

PMID38648977
PMCPMC13138505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.